journal article·2020-12

Enhancement of Nanozyme Permeation by Endovascular Interventional Treatment to Prevent Vascular Restenosis via Macrophage Polarization Modulation

Lishuai Feng, Chaoran Dou, Yuguo Xia, Benhao Li, Mengyao Zhao, Ahmed Mohamed El‐Toni, Nada Farouk Atta, Yuanyi Zheng, Xiaojun Cai, Yan Wang, Yingsheng Cheng, Fan Zhang

Advanced Functional Materials· Volume 30· Issue 52
Publisher page

Abstract

Abstract The long‐term prognosis of vascular restenosis after endovascular interventional treatment is a critical challenge in a clinical setting. Over‐production of reactive oxygen species (ROS) is a major factor to aggravate vascular restenosis. Current clinical pharmacological interventions for vascular restenosis are still unsatisfactory. Based on the intrinsic ROS scavenging properties, nanozymes have been widely applied in the treatment of inflammatory‐related diseases. However, the vascular endothelial cell barrier hinder the delivery efficiency of intravenously injected nanomaterials in most diseases. Herein, an effective therapeutic strategy for vascular restenosis is developed based on endothelial cells exfoliation by endovascular interventional treatment through vascular balloon injury, which provides an opportunity to enhance nanozyme passive permeation into the vascular intima and uptake by macrophages to alleviate long‐term vascular restenosis in vivo. Moreover, the macrophages polarization modulation mechanism of vascular restenosis prevention is further investigated. This interesting discovery that endothelial cells exfoliation enhanced nanoparticle vascular permeation by endovascular interventional treatment may provide applicative perspectives in the treatment of other disease by nanomaterials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Nanocluster Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Radiology Department of Ultrasound in Medicine Department of Neurosurgery Shanghai Jiao Tong University Affiliated Sixth People's Hospital No. 600, Yishan Road Shanghai 200233 P. R. China

Department of Chemistry State Key Laboratory of Molecular Engineering of Polymers and Shanghai Key Laboratory of Molecular Catalysis and Innovative Materials and iChem Fudan University Shanghai 200433 P. R. China

King Abdullah Institute for Nanotechnology King Saud University Riyadh 11451 Saudi Arabia

Central Metallurgical Research and Development Institute CMRDI Helwan Cairo 11421 Egypt

Department of Chemistry Cairo University Giza Cairo 12613 Egypt

Funding

King Saud University · China National Funds for Distinguished Young Scientists

References (59)

Show source-provided references
1. 10.1016/S1474-4422(18)30195-910.1016/S1474-4422(18)30195-9 ↗
2. 10.1038/nrcardio.2011.14810.1038/nrcardio.2011.148 ↗
3. 10.1016/j.jcin.2018.03.03810.1016/j.jcin.2018.03.038 ↗
4. 10.1016/j.jvs.2009.08.04010.1016/j.jvs.2009.08.040 ↗
5. 10.1016/S1474-4422(12)70159-X10.1016/S1474-4422(12)70159-X ↗
6. 10.1161/STROKEAHA.116.01265010.1161/STROKEAHA.116.012650 ↗
7. 10.1016/j.jacc.2012.11.06810.1016/j.jacc.2012.11.068 ↗
8. 10.1038/nrm225610.1038/nrm2256 ↗
9. 10.1039/C8CS00457A10.1039/C8CS00457A ↗
10. 10.1021/acs.chemrev.8b0067210.1021/acs.chemrev.8b00672 ↗
11. 10.1021/acs.chemrev.8b0062610.1021/acs.chemrev.8b00626 ↗
12. 10.1002/adma.20190295610.1002/adma.201902956 ↗
13. 10.1002/anie.20191218210.1002/anie.201912182 ↗
14. 10.1021/jacs.8b0522310.1021/jacs.8b05223 ↗
15. 10.1016/j.molliq.2020.11306610.1016/j.molliq.2020.113066 ↗
16. 10.1021/jacs.5b1207010.1021/jacs.5b12070 ↗
17. 10.1021/jacs.9b1287310.1021/jacs.9b12873 ↗
18. 10.1002/anie.20171246910.1002/anie.201712469 ↗
19. 10.1002/adma.20190189310.1002/adma.201901893 ↗
20. 10.1039/C8CS00718G10.1039/C8CS00718G ↗
21. 10.1039/C7SC05476A10.1039/C7SC05476A ↗
22. 10.1038/s41563-019-0566-210.1038/s41563-019-0566-2 ↗
23. 10.1002/adma.20190489410.1002/adma.201904894 ↗
24. 10.1038/s41467-018-03705-y10.1038/s41467-018-03705-y ↗
25. 10.1016/j.jconrel.2017.09.01610.1016/j.jconrel.2017.09.016 ↗
26. 10.1002/adma.20190151310.1002/adma.201901513 ↗
27. 10.1021/acsnano.8b0199410.1021/acsnano.8b01994 ↗
28. 10.1039/C8CS00081F10.1039/C8CS00081F ↗
29. 10.1002/adfm.20160579510.1002/adfm.201605795 ↗
30. 10.1038/nmat471810.1038/nmat4718 ↗
31. 10.7150/ntno.3005210.7150/ntno.30052 ↗
32. 10.1161/ATVBAHA.115.30703110.1161/ATVBAHA.115.307031 ↗
33. 10.1016/j.lfs.2019.11698510.1016/j.lfs.2019.116985 ↗
34. 10.1038/s41419-019-1667-110.1038/s41419-019-1667-1 ↗
35. 10.1038/nature1203410.1038/nature12034 ↗
36. 10.1038/nri307310.1038/nri3073 ↗
37. 10.3389/fimmu.2014.0057910.3389/fimmu.2014.00579 ↗
38. 10.1161/01.RES.0000261350.61711.9e10.1161/01.RES.0000261350.61711.9e ↗
39. 10.1096/fj.201800173R10.1096/fj.201800173R ↗
40. 10.1016/j.intimp.2018.07.01310.1016/j.intimp.2018.07.013 ↗
41. 10.1038/cr.2013.8810.1038/cr.2013.88 ↗
42. 10.1016/j.imbio.2018.11.01010.1016/j.imbio.2018.11.010 ↗
43. 10.1021/acsami.8b1034510.1021/acsami.8b10345 ↗
44. 10.1002/adma.20150338110.1002/adma.201503381 ↗
45. 10.1021/acs.nanolett.8b0472910.1021/acs.nanolett.8b04729 ↗
46. 10.1039/D0TB01248C10.1039/D0TB01248C ↗
47. 10.1021/acs.analchem.7b0488310.1021/acs.analchem.7b04883 ↗
48. 10.1016/j.biomaterials.2014.09.00410.1016/j.biomaterials.2014.09.004 ↗
49. 10.1007/978-981-15-1490-6_610.1007/978-981-15-1490-6_6 ↗
50. 10.1016/j.atherosclerosis.2019.08.02310.1016/j.atherosclerosis.2019.08.023 ↗
51. 10.1038/nature1537310.1038/nature15373 ↗
52. 10.1016/j.bbrc.2017.06.19910.1016/j.bbrc.2017.06.199 ↗
53. Feng L. · Int. J. Mol. Med. · 2018 · 42 · 1074
54. 10.1016/j.biopha.2018.04.03910.1016/j.biopha.2018.04.039 ↗
55. 10.1016/j.redox.2017.11.02710.1016/j.redox.2017.11.027 ↗
56. 10.1096/fj.14-26536310.1096/fj.14-265363 ↗
57. 10.3389/fimmu.2018.0311810.3389/fimmu.2018.03118 ↗
58. 10.2337/db14-092910.2337/db14-0929 ↗
59. 10.3389/fimmu.2018.0117510.3389/fimmu.2018.01175 ↗